BriefCase vs Viz CTP
AI Verdict
Choose BriefCase if…
Choose BriefCase if your primary need is to optimize the communication and collaboration workflow *after* critical medical imaging findings have been identified by an AI platform. It excels at ensuring timely, secure, and auditable sharing of urgent findings among care teams, with features like automated follow-up and customizable protocols to streamline responses.
View BriefCase →Choose Viz CTP if…
Choose Viz CTP if your organization requires a broad AI-powered solution for *detecting a wide range of diseases* directly from medical imaging and accelerating the entire care pathway from diagnosis to treatment. Its strength lies in leveraging numerous FDA-cleared algorithms for automated image analysis, providing real-time mobile access to high-fidelity imaging, and facilitating intelligent care coordination for faster clinical interventions.
View Viz CTP →When choosing between Aidoc’s BriefCase and Viz.ai’s Viz CTP, physicians should consider their primary need: enhanced communication of critical findings or comprehensive AI-powered disease detection and workflow optimization. BriefCase excels at streamlining the communication and collaboration surrounding critical medical imaging findings, integrating with the broader Aidoc platform to ensure urgent cases receive immediate attention and follow-up. Its strength lies in its customizable communication protocols, automated reminders, and robust audit trails, making it ideal for large hospitals and health systems focused on improving care team coordination around already identified critical findings.
In contrast, Viz CTP offers a more expansive suite of AI-powered disease detection and intelligent care coordination capabilities. With over 50 FDA-cleared algorithms, it analyzes medical imaging for conditions like large vessel occlusions (LVOs) and intracranial hemorrhages (ICH), providing real-time mobile access to high-fidelity imaging and automated measurements. The key practical difference is that BriefCase focuses on optimizing the communication *after* a critical finding is identified (often by the Aidoc platform), while Viz CTP actively *detects* diseases and then facilitates care coordination around those detections. Physicians primarily seeking advanced AI for disease detection, image analysis, and subsequent workflow prioritization, particularly in specialties like neurology and emergency medicine, would likely find Viz CTP more aligned with their needs. Those prioritizing robust, auditable communication and collaboration around critical findings within an existing AI detection framework may favor BriefCase.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz CTPViz CTP (Tool B) explicitly highlights 'real-time, mobile access to high-fidelity imaging (DICOM viewer, 3D manipulation)', suggesting a more interactive and direct image review experience on mobile. In contrast, BriefCase (Tool A) provides 'compressed preview images that are meant for informational purposes only and not intended for diagnostic use beyond notification', indicating a less diagnostic-focused mobile imaging experience.
Clinical Value
Viz CTPViz CTP (Tool B) offers a broader and deeper direct clinical impact with 'over 50 FDA-cleared algorithms' for disease detection, automated image analysis, interpretation, motion artifact correction, and automated measurements. Studies also show its effectiveness in reducing transfer times and length of stay for stroke patients. BriefCase (Tool A) focuses more on workflow triage and communication of findings from its underlying Aidoc platform, though it also has quantification capabilities and algorithms for specific conditions.
Pricing & Value
TieBoth tools employ custom enterprise/subscription pricing models with a lack of public transparency regarding specific costs. While Viz CTP (Tool B) has strong clinical validation demonstrating improved patient outcomes and cost savings, BriefCase (Tool A) offers flexible payment options through third-party financing. Without clear pricing details for either, a definitive winner on overall pricing and value cannot be determined.
Enterprise Readiness
Viz CTPViz CTP (Tool B) demonstrates superior enterprise readiness by explicitly listing a wider array of certifications, including SOC 2 Type II, GDPR, and multiple ISO standards (27001, 27701, 27799). Furthermore, it reports deployment in nearly 2,000 hospitals globally, a higher customer count than BriefCase's (Tool A) 500+ hospitals, indicating broader adoption and validation in large health systems.
Innovation
Viz CTPViz CTP (Tool B) is a recognized pioneer in AI-powered disease detection and care coordination, boasting 'over 50 FDA-cleared algorithms' and advanced features like motion artifact correction and automated measurements. Its recent expansion into multimodal AI agent platforms also showcases continuous innovation. While BriefCase (Tool A) is leveraging a 'foundation model AI' and developing automated reporting, Viz CTP's established breadth and depth of direct clinical AI applications give it an edge.
Support & Docs
Viz CTPViz CTP (Tool B) provides comprehensive and explicit support details, including 24/7/365 urgent phone support, email support, a dedicated Help Center, Knowledge Base, User Guides, and a 'Viz Academy' for educational resources. BriefCase (Tool A) mentions general support and access to AI experts but lacks the specific, detailed offerings found for Tool B.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | BriefCase | Viz CTP |
|---|---|---|
| Product Name | BriefCase | Viz CTP |
| Company | Aidoc Medical | Viz.ai |
| Tagline | AI-driven communication and collaboration for critical medical imaging findings. | AI-powered disease detection and intelligent care coordination |
| Mobile Access | both (mobile app) | Real-time, mobile access to high-fidelity imaging (DICOM viewer, 3D manipulation) |
| Primary AI Focus | AI-driven critical finding detection (via Aidoc platform) | AI-powered disease detection (50+ FDA-cleared algorithms), Automated image analysis and interpretation |
| Care Coordination/Communication | Secure, real-time communication of findings; Customizable communication protocols; Automated follow-up tracking and reminders; Prioritization of urgent cases for immediate attention; Mobile access for care team collaboration | Intelligent care coordination and communication platform (HIPAA-compliant messaging) |
Videos
Demos, reviews, and walkthroughs featuring BriefCase and Viz CTP.